FDA Releases Guidance on Nonclinical Safety Evaluation of Drug or Biologic Combinations

Summary

The Food and Drug Administration (FDA) has made available a new guidance document that outlines nonclinical safety evaluation approaches for fixed-dose combination products, co-packaged products, and some adjunctive therapies, aiming to support clinical studies and product approvals.